Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2024

Feb 6, 2024

31971_dirs_2024-02-05_ead27205-9864-4907-89c7-f4a880ab31d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-12-31

Reporting Person: Lalomia Brent (Vice President QA and RA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-31 401 (K) Plan J 18.243 $109.51 Acquired 70.613 Indirect

Footnotes

F1: As of 12/31/23.